Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Fifteen pharmaceutical and life sciences companies will work with the Bill and Melinda Gates Foundation to accelerate the development of vaccines, diagnostics, and treatments for COVID-19. The group will share proprietary compound libraries, along with safety and activity data, with the COVID-19 Therapeutics Accelerator, an effort the foundation launched last month with Wellcome and Mastercard. The 15 firms are also involved in other partnerships to develop COVID-19 therapies.
C&EN has made this story and all of its coverage of the coronavirus epidemic freely available during the outbreak to keep the public informed. To support our journalism, become a member of ACS or sign up for C&EN's weekly newsletter.
This article has been sent to the following recipient: